- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT00899782
Collection and Storage of Blood and Tissue Samples From Patients Who Are Undergoing Surgery For Lung Cancer
The CALGB Lung Cancer Tissue Bank
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
OBJECTIVES:
- To collect, catalog and store frozen samples of lung carcinoma and when possible, portions of involved lymph nodes, as well as adjacent grossly uninvolved lung tissue obtained from surgical specimens of patients undergoing surgical resection for previously untreated lung cancer as a source of quality DNA, messenger ribonucleic acid (mRNA) and protein for molecular analysis.
- To collect, catalog and store frozen samples of blood pre- and post-resection from the same patients to provide a source of reference DNA to assess somatic mutations associated with tumor or preneoplastic "normal" lung, and to allow assessment of levels of circulating markers.
- To associate these specimens with historical, clinical, pathological, and outcome information.
Grossly viable tumor and grossly normal lung tissue are identified and removed from patient surgical specimens and cryopreserved until shipment to the Cancer and Leukemia Group B (CALGB) Lung Cancer Tissue Bank for future use in research. Blood specimens are also collected prior to surgery and at 4-12 weeks post-surgery (before the start of adjuvant therapy) and shipped immediately to the Tissue Bank.
Type d'étude
Inscription (Anticipé)
Contacts et emplacements
Lieux d'étude
-
-
Delaware
-
Lewes, Delaware, États-Unis, 19958
- Tunnell Cancer Center at Beebe Medical Center
-
Newark, Delaware, États-Unis, 19713
- CCOP - Christiana Care Health Services
-
-
Maryland
-
Elkton, Maryland, États-Unis, 21921
- Union Hospital of Cecil County
-
-
Massachusetts
-
Boston, Massachusetts, États-Unis, 02115
- Dana-Farber/Brigham and Women's Cancer Center
-
Boston, Massachusetts, États-Unis, 02115
- Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
-
-
Minnesota
-
Minneapolis, Minnesota, États-Unis, 55455
- Masonic Cancer Center at University of Minnesota
-
-
Missouri
-
Columbia, Missouri, États-Unis, 65203
- Ellis Fischel Cancer Center at University of Missouri - Columbia
-
Saint Louis, Missouri, États-Unis, 63110
- Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
-
-
New Jersey
-
Voorhees, New Jersey, États-Unis, 08043
- Cancer Institute of New Jersey at Cooper - Voorhees
-
-
New York
-
Buffalo, New York, États-Unis, 14263-0001
- Roswell Park Cancer Institute
-
Syracuse, New York, États-Unis, 13210
- SUNY Upstate Medical University Hospital
-
-
North Carolina
-
Asheville, North Carolina, États-Unis, 28805
- Veterans Affairs Medical Center - Asheville
-
Durham, North Carolina, États-Unis, 27710
- Duke Cancer Institute
-
-
Pennsylvania
-
Monroeville, Pennsylvania, États-Unis, 15146
- Forbes Regional Hospital
-
Natrona Heights, Pennsylvania, États-Unis, 15065
- Alle-Kiski Medical Center
-
Pittsburgh, Pennsylvania, États-Unis, 15212
- Allegheny Cancer Center at Allegheny General Hospital
-
-
Rhode Island
-
Providence, Rhode Island, États-Unis, 02906
- Miriam Hospital
-
Providence, Rhode Island, États-Unis, 02903
- Rhode Island Hospital Comprehensive Cancer Center
-
-
Vermont
-
Burlington, Vermont, États-Unis, 05401
- Fletcher Allen Health Care - University Health Center Campus
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
- Histologic Documentation: All patients with suspected or histologically documented previously untreated lung cancer undergoing surgical resection are eligible whether or not the patient participates in a CALGB-sponsored treatment trial; patients enrolled on a CALGB trial of preoperative chemotherapy for lung cancer will be eligible if a pre-treatment frozen sample of tumor (e.g., a positive lymph node from mediastinoscopy) can be submitted to the bank; patients enrolled on CALGB 140203, intraoperative sentinel node mapping in non-small cell lung cancer, are not eligible.
- No patients with known infectious disease, such as human immunodeficiency virus (HIV), tuberculosis (TB), or hepatitis B, C
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: Cas uniquement
- Perspectives temporelles: Éventuel
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
---|---|
Ancillary-Correlative (lung cancer tissue bank)
Grossly viable tumor and grossly normal lung tissue are identified and removed from patient surgical specimens and cryopreserved until shipment to the CALGB Lung Cancer Tissue Bank for future use in research.
Blood specimens are also collected prior to surgery and at 4-12 weeks post-surgery (before the start of adjuvant therapy) and shipped immediately to the Tissue Bank.
|
correlative studies
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
---|---|
Collection and storage of frozen tissue samples for molecular analysisor resection of lung cancer
Délai: Up to 5 years
|
Up to 5 years
|
Collection and storage of frozen blood samples for the assessment of somatic mutations and levels of circulating markersto assess levels of circulating markers
Délai: Up to 5 years
|
Up to 5 years
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chaise d'étude: William Richards, MD, Brigham and Women's Cancer Center
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- CALGB-140202
- U10CA180821 (Subvention/contrat des NIH des États-Unis)
- U10CA031946 (Subvention/contrat des NIH des États-Unis)
- CDR0000271323 (Identificateur de registre: NCI Physician Data Query)
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .